Oral therapies in digestive oncology (Review). 2020

Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
Department of Hepatology and Gastroenterology, Percy Military Hospital, 92140 Clamart, France.

Targeted therapy and oral chemotherapy indications are increasing in the realm of digestive oncology. Oral intake of cancer agents is sometimes compulsory (no i.v. equivalent) or is preferred by the patient or the physician. Although oral chemotherapy facilitates the treatment of oncology patients, the treatment diversity, risk of pharmaceutical interactions and monitoring of side effects are potentially challenging and need to be fully acknowledged by the physician. We offer here a literature review of the indications, doses, side effects and monitoring of every oral therapy indicated in Digestive Oncology. We suggest a prescription algorithm including therapeutic education by the physician or a trained nurse, and pharmaceutical counseling.

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004067 Digestive System Neoplasms Tumors or cancer of the DIGESTIVE SYSTEM. Cancer of Digestive System,Digestive System Cancer,Cancer of the Digestive System,Neoplasms, Digestive System,Cancer, Digestive System,Cancers, Digestive System,Digestive System Cancers,Digestive System Neoplasm,Neoplasm, Digestive System
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D058990 Molecular Targeted Therapy Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease. Targeted Molecular Therapy,Molecular Targeted Therapies,Molecular Therapy, Targeted,Targeted Molecular Therapies,Targeted Therapy, Molecular,Therapy, Molecular Targeted,Therapy, Targeted Molecular

Related Publications

Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
August 2012, Pathologie-biologie,
Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
May 2011, Revue medicale suisse,
Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
September 2006, Internal medicine journal,
Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
August 2022, JCO oncology practice,
Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
November 1994, Presse medicale (Paris, France : 1983),
Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
January 2008, Bulletin du cancer,
Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
April 1989, Gastroenterologie clinique et biologique,
Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
December 2007, La Revue du praticien,
Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
February 2016, Nature reviews. Drug discovery,
Caroline Prieux-Klotz, and Solene Dermine, and Lola-Jade Palmieri, and Julie Lavole, and Stanislas Chaussade, and Catherine Brezault, and Romain Coriat
May 2009, Journal de chirurgie,
Copied contents to your clipboard!